Page last updated: 2024-09-03

xaliproden and Peripheral Nerve Diseases

xaliproden has been researched along with Peripheral Nerve Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barton, D; Grothey, A; Kottschade, L; Loprinzi, C; Wolf, S1
Susman, E1
D'Orazio, A; Gibson, TB; Ranganathan, A1
Bougault, I; Coudé, FX; Fournier, J; Gauthier, T; Guzzi, U; Keane, PE; Le Fur, G; Maffrand, JP; Soubrié, P; Steinberg, R1

Reviews

1 review(s) available for xaliproden and Peripheral Nerve Diseases

ArticleYear
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:11

    Topics: Acetylcarnitine; Acetylcysteine; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Calcium; Glutamine; Humans; Infusions, Intravenous; Ketamine; Magnesium; Naphthalenes; Nootropic Agents; Paclitaxel; Peripheral Nervous System Diseases; Pyridines; Randomized Controlled Trials as Topic; Vitamin E

2008

Other Studies

3 other study(ies) available for xaliproden and Peripheral Nerve Diseases

ArticleYear
Xaliproden lessens oxaliplatin-mediated neuropathy.
    The Lancet. Oncology, 2006, Volume: 7, Issue:4

    Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridines

2006
Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006.
    Clinical colorectal cancer, 2006, Volume: 5, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Clinical Trials as Topic; Colorectal Neoplasms; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Neoplasms; Humans; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridines; Serotonin Receptor Agonists

2006
Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates.
    Neuroscience, 1993, Volume: 55, Issue:3

    Topics: Acetylcholinesterase; Acrylamide; Acrylamides; Animals; Biomarkers; Brain Ischemia; Callithrix; Choline O-Acetyltransferase; Female; Hippocampus; Male; Naphthalenes; Nerve Crush; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Peripheral Nervous System Diseases; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Sciatic Nerve; Septum Pellucidum; Serotonin Receptor Agonists; Species Specificity; Vincristine

1993